I agree
This is a pivot from selling after Phase 2 results to now gearing up to get a phase 3 trial up and running and from there go for FDA approval
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-43
-
- There are more pages in this discussion • 464 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $440.9M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.2¢ | 5.7¢ | $1.560M | 26.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 934124 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 857268 | 27 |
View Market Depth
| Last trade - 13.16pm 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |